Individualized Cognition-Action intervention to prevent behavioral disturbances and functional decline in institutionalized older adults: a randomized pilot trial

International Journal of Geriatric Psychiatry
Arnaud DechampsPatrick Dehail

Abstract

To evaluate the effectiveness of an individualized Cognition-Action (CA) intervention to reduce behavioral disturbances in severely deconditioned institutionalized old adults. 12 weeks randomized pilot trial of either individualized Cognition-Action program (n = 24) or routine medical care as control (C, n = 25). Long-term care (LTC) of the Geriatric Department from the University State Hospital in Bordeaux, France. 49 institutionalized old patients with at least one Neuropsychiatric symptoms > or =4. The CA rationale was a non-preconceived ideas approach over the patient's abilities and discourse. Patients received short bouts of 5-15 min and accumulated 50 min of interaction per week. CA intervention used five standardized exercises as tools to enhance communication and social interactions. CA was compared to usual care. Primary outcomes were the Neuropsychiatric inventory (NPI) total and symptoms scores. Secondary outcomes were the BERG balance scale, the Geriatric Depression Scale (GDS), Quality of life AM-PAC-CAT and Muscle strength. The CA group had a clinically significant NPI total score reduction compared to C, -7, 95%CI [-10.8 to -3], eta2 = 0.24. CA group showed a risk reduction of NPI total score worsening, OR = 0.0...Continue Reading

References

Mar 1, 1994·Journal of Clinical Psychology·E L Lesher, J S Berryhill
Jan 27, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·D A LazowskiD A Cunningham
Mar 25, 2000·Journal of the American Geriatrics Society·C Christmas, R A Andersen
May 22, 2002·Psychosomatic Medicine·Rebecca G LogsdonLinda Teri
Oct 31, 2002·Psychiatric Services : a Journal of the American Psychiatric Association·Cameron J CampElizabeth A Capezuti
Oct 16, 2003·JAMA : the Journal of the American Medical Association·Linda TeriEric B Larson
Feb 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stanley J ColcombeSteriani Elavsky
Jun 17, 2006·Journal of Applied Physiology·Arthur F KramerStanley J Colcombe
Aug 1, 2006·Archives of Physical Medicine and Rehabilitation·Stephen M HaleyPengsheng Ni
Feb 17, 2007·Journal of the American Geriatrics Society·Yves RollandBruno Vellas
Feb 22, 2007·Physical Therapy·Alan M JetteMatthew Zurek
Nov 8, 2007·Dementia and Geriatric Cognitive Disorders·Pauline AaltenPhilippe H Robert
May 20, 2008·International Journal of Geriatric Psychiatry·Arnaud DechampsIsabelle Bourdel-Marchasson
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Apr 17, 2009·International Journal of Geriatric Psychiatry·Audrey DeudonPhilippe Henri Robert
May 20, 2009·Journal of Aging and Physical Activity·Arnaud DeschampsIsabelle Bourdel-Marchasson

❮ Previous
Next ❯

Citations

Sep 8, 2012·Current Gerontology and Geriatrics Research·Elsa LeoneArnaud Dechamps
Jun 10, 2015·Neuroscience and Biobehavioral Reviews·Soledad BallesterosChariklia Tziraki
Jan 30, 2019·The Journal of Nursing Research : JNR·Su Jung LeeSung Ok Chang
Dec 20, 2018·Journal of the American Geriatrics Society·Chunxiao WuChunzhi Tang
Mar 2, 2013·The Cochrane Database of Systematic Reviews·Tom CrockerDarren C Greenwood
Dec 29, 2020·Scandinavian Journal of Caring Sciences·Minna LaunonenTarja Kvist

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.